FEDERAL CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF PNEUMOCONIOSIS

The purpose of development of this clinical practice guidelines was to provide evidence-based protocols that help the practitioner and the patient make the right decision for the health assessment, treatment and prevention of pneumoconiosis. Pneumoconiosis is the interstitial lung disease of occupat...

Full description

Saved in:
Bibliographic Details
Published inMeditsina truda i promyshlennaia ekologiia no. 1; p. 36
Main Authors Artemoval, L V, Baskova, N V, Burmistrova, T B, Buryakinal, E A, Buhtiyarov, I V, Bushmanov, A Yu, Vasilyeva, O S, Vlasov, V G, Gorblyansky, Y Y, Zhabina, S A, Zaharinskaya, O N, Ismerov, N F, Kovalevsky, E V, Kuznetsova, G V, Kuzmina, L P, Kunyaeva, T A, Logvinenko, I I, Lutsenko, L A, Mazitova, N N, Obukhova, T Yu, Odintseva, O V, Orlova, G P, Panacheva, L A, Piktushanskaya, I N, Plyukhin, A E, Poteryaeva, E L, Pravilo, S M, Razumov, V V, Roslaya, N A, Roslyi, O F, Rushkevich, O P, Semenihin, V A, Serebryakov, P V, Smirnova, E L, Sorkina, N S, Tsidil'kovskaya, E S, Chasovskikh, E V, Shpagina, L A
Format Journal Article
LanguageRussian
Published Russia (Federation) 2016
Subjects
Humans
Occupational Diseases - diagnosis
Occupational Diseases - prevention & control
Occupational Diseases - therapy
Pneumoconiosis - diagnosis
Pneumoconiosis - prevention & control
Pneumoconiosis - therapy
Practice Guidelines as Topic - standards
Russia
Russia
Online AccessGet more information

Cover

More Information
Summary:The purpose of development of this clinical practice guidelines was to provide evidence-based protocols that help the practitioner and the patient make the right decision for the health assessment, treatment and prevention of pneumoconiosis. Pneumoconiosis is the interstitial lung disease of occupational origin caused by prolonged inhalation of inorganic dust, characterized by chronic diffuse aseptic inflammation in lung tissue with the development of pulmonary fibrosis. Currently, thereare no treatment that provide a cure pulmonary fibrosis and changes in the dynamics of decline in lung function. Regular, individually tailored treatment should be directed to the pathogenic mechanisms and some clinical symptoms of pneumoconiosis, as well as the prevention of complications. To enhance the effect of pharmacotherapy is recommended to use non-drug therapies that enhance the functionality of the respiratory system.
ISSN:1026-9428